Aviscumine Uses, Dosage, Side Effects and more
Cy 503 is under investigation in clinical trial NCT00658437 (Aviscumine for the Treatment of Malignant Melanoma Stage IV After Failure of Prior Therapy).
| Trade Name | Aviscumine |
| Generic | Aviscumine |
| Aviscumine Other Names | Aviscumine |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
